648
Views
6
CrossRef citations to date
0
Altmetric
Articles

Consumer’s Regulatory Knowledge of Prescription Drug Advertising and Health Risk Awareness: The Moderating Role of Risk Information Prominence

, &

References

  • Ad Age Datacenter. (2017). U.S. Measured-media advertising spending by category. Retrieved from http://adage.com/article/datacenter/200-leading-national-advertisers/309283/
  • Ahn, H. A., Park, J. S., & Haley, E. (2014). Consumers’ optimism bias and responses to risk disclosures in direct-to-consumer (DTC) prescription drug advertising: The moderating role of subjective health literacy. Journal of Consumer Affairs, 48(1), 175–194. doi:10.1111/joca.12028
  • Aikin, K. J., Swasy, J. L., & Braman, A. C. (2004). Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs: Summary of FDA survey research results. Retrieved from http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/DrugMarketingAdvertisingandCommunicationsResearch/ucm151498.htm
  • Alba, J. W., & Hutchinson, J. W. (1987). Dimensions of consumer expertise. Journal of Consumer Research, 13(4), 411–454. doi:10.1086/jcr.1987.13.issue-4
  • Andrews, J. C., Netemeyer, R. G., & Burton, S. (2009). The nutrition elite: Do only the highest levels of caloric knowledge, obesity knowledge, and motivation matter in processing nutrition ad claims and disclosures? Journal of Public Policy & Marketing, 28(1), 41–55. doi:10.1509/jppm.28.1.41
  • Avery, R. J., Eisenberg, M., & Simon, K. I. (2012). Fair balance in direct-to-consumer antidepressant print and television advertising, 1995–2007. Journal of Health Communication, 17(3), 250–277. doi:10.1080/10810730.2011.585698
  • Avery, R. J., Kenkel, D., Lillard, D. R., Mathios, A., & Wang, H. (2008). Health disparities and direct-to-consumer advertising of pharmaceutical products. Advances in Health Economics & Health Services Research, 19, 71–94.
  • Bearden, W. O., Hardesty, D. M., & Rose, R. L. (2001). Consumer self-confidence: Refinements in conceptualization and measurement. Journal of Consumer Research, 28(1), 121–134. doi:10.1086/321951
  • Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (1999). Direct-to-consumer advertising and the public. Journal of General Internal Medicine, 14(11), 651–657.
  • Bell, R. A., Wilkes, M. S., & Kravitz, R. L. (1999). Advertisement-induced prescription drug requests: Patients’ anticipated reactions to a physician who refuses. Journal of Family Practice, 48(6), 446–452.
  • Bettman, J. R., Payne, J. W., & Staelin, R. (1986). Cognitive considerations in designing effective labels for presenting risk information. Journal of Public Policy and Marketing, 5, 1–28. doi:10.1177/074391568600500101
  • Blackwell, R. D., Miniard, P. W., & Engel, J. F. (2006). Consumer behavior (10th ed.). Mason, OH: Thomson Southwestern.
  • Brucks, M. (1985). The effects of product class knowledge on information search behavior. Journal of Consumer Research, 12(1), 1–16. doi:10.1086/jcr.1985.12.issue-1
  • Campbell, M. C., & Kirmani, A. (2000). Consumers’ use of persuasion knowledge: The effects of accessibility and cognitive capacity on perceptions of an influence agent. Journal of Consumer Research, 27(1), 69–83. doi:10.1086/314309
  • Campbell, M. C., & Kirmani, A. (2008). I know what you’re doing and why you’re doing it: The use of persuasion knowledge model in consumer research. In C. P. Haugtvedt, P. M. Herr, & F. R. Kardes (Eds.), Handbook of consumer psychology (pp. 549–574)). New York, NY: Psychology Press.
  • Chaffee, S. H., & Schleuder, J. (1986). Measurement and effects of attention to media news. Human Communication Research, 13(1), 76–107. doi:10.1111/hcre.1986.13.issue-1
  • Cordell, V. V. (1997). Consumer knowledge measures as predictors in product evaluation. Psychology & Marketing, 14(3), 241–260. doi:10.1002/(ISSN)1520-6793
  • Cox, A. D., Cox, D., & Mantel, S. P. (2010). Consumer response to drug risk information: The role of positive affect. Journal of Marketing, 74(4), 31–44.
  • Davis, J. J. (2000). Riskier than we think? the relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drug. Journal of Health Communication, 5(4), 349–369. doi:10.1080/10810730050199141
  • Davis, J. J. (2010). The effect of placement and modality on the recall of information from pharmaceutical web sites. Journal of Medical Marketing, 10(2), 99–114. doi:10.1057/jmm.2009.42
  • Davis, J. J., & Meader, A. (2009). Beyond content analysis: Assessing fair balance in DTC pharmaceutical advertising. Journal of Medical Marketing, 9(1), 57–66. doi:10.1057/jmm.2008.31
  • Deubel, H., & Schneider, W. X. (1996). Saccade target selection and object recognition: Evidence for a common attentional mechanism. Vision Research, 36(12), 1827–1837.
  • FDA. (2009). Guidance for industry: Presenting risk information in prescription drug and medical device promotion (draft guidance). Retrieved from https://www.fda.gov/downloads/drugs/guidances/ucm155480.pdf
  • FDA. (2018). Prescription drug advertising: Questions and answers. Retrieved from https://www.fda.gov/Drugs/ResourcesForYou/Consumers/PrescriptionDrugAdvertising/ucm076768.htm
  • Friestad, M., & Wright, P. (1994). The persuasion knowledge model: How people cope with persuasion attempts. Journal of Consumer Research, 21(1), 1–31. doi:10.1086/jcr.1994.21.issue-1
  • Frosch, D. L., Grande, D., Tarn, D. M., & Kravitz, R. L. (2010). A decade of controversy: Balancing policy with evidence in the regulation of prescription drug advertising. American Journal of Public Health, 100(1), 24–32. doi:10.2105/AJPH.2008.153767
  • FTC. (2013). .com disclosures: How to make effective disclosures in digital advertising. Retrieved from https://www.ftc.gov/sites/default/files/attachments/press-releases/ftc-staff-revises-online-advertising-disclosure-guidelines/130312dotcomdisclosures.pdf
  • Goodrich, K. (2011). Anarchy of effects? Exploring attention to online advertising and multiple outcomes. Psychology & Marketing, 28(4), 417–440. doi:10.1002/mar.v28.4
  • Greenwald, A. G., & Leavitt, C. (1984). Audience involvement in advertising: Four levels. Journal of Consumer Research, 11(1), 11–32. doi:10.1086/jcr.1984.11.issue-1
  • Haugtvedt, C. P., Liu, K., & Min, K. S. (2008). Individual differences: Tools for theory testing and understanding in consumer psychology research. In C. P. Haugtvedt, P. M. Herr, & F. R. Kardes (Eds.), Handbook of consumer psychology (pp. 1161–1175). New York, NY: Psychology Press.
  • Hayes, A. F. (2013). Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. New York, NY: Guilford Press.
  • Hoy, M. G., & Andrews, J. C. (2004). Adherence of prime-time televised advertising disclosures to the “clear and conspicuous” standard: 1990 versus 2002. Journal of Public Policy and Marketing, 23(2), 170–182. doi:10.1509/jppm.23.2.170.51397
  • Hoy, M. G., & Levenshus, A. B. (2018). A mixed-methods approach to assessing actual risk readership on branded drug websites. Journal of Risk Research, 21(5), 521–538. doi:10.1080/13669877.2016.1223160
  • Hoy, M. G., & Park, J. S. (2014). Principles in action: An examination of food and drug administration letters involving violative internet promotions from 1997 to 2012. Journal of Public Policy & Marketing, 33(2), 127–142. doi:10.1509/jppm.12.097
  • Janiszewski, C., Kuo, A., & Tavassoli, N. T. (2013). The influence of selective attention and inattention to products on subsequent choice. Journal of Consumer Research, 39(6), 1258–1274. doi:10.1086/668234
  • Johnson, E. J., & Russo, J. E. (1984). Product familiarity and learning new information. Journal of Consumer Research, 11(1), 542–550. doi:10.1086/jcr.1984.11.issue-1
  • Ju, I. (2017). The effects of advertising skepticism in consumer prescription drug advertising: The moderating role of risk disclosure location. International Journal of Pharmaceutical and Healthcare Marketing, 11(4), 395–411. doi:10.1108/IJPHM-10-2016-0054
  • Kantar Media Intelligence. (2016). Ad$pender. Retrieved from http://products.kantarmediana.com/security/
  • Kavadas, C., Katsanis, L. P., & LeBel, J. (2007). The effects of risk disclosure and ad involvement on consumers in DTC advertising. Journal of Consumer Marketing, 24(3), 171–179. doi:10.1108/07363760710746175
  • Kruglanski, A. W., & Webster, D. M. (1996). Motivated closing of the mind: “Seizing” and “freezing.”. Psychological Review, 103(2), 263–283.
  • Kunda, Z. (1990). The case for motivated reasoning. Psychological Bulletin, 108(3), 480–498.
  • Lavie, N. (2001). Capacity limits in selective attention: Behavioral evidence and implications for neural activity. In J. Braun, C. Koch, & J. L. Davis (Eds.), Visual attention and cortical circuits (pp. 49–68). Cambridge, MA: The MIT Press.
  • Lynch, Jr., J. G., Jr., & Srull, T. K. (1982). Memory and attentional factors in consumer choice: Concepts and research methods. Journal of Consumer Research, 9(1), 18–37. doi:10.1086/jcr.1982.9.issue-1
  • MacInnis, D. J., & Jaworski, B. J. (1989). Information processing from advertisements: Toward an integrative framework. Journal of Marketing, 53(4), 1–23. doi:10.1177/002224298905300401
  • Mackenzie, S. B. (1986). The role of attention in mediating the effect of advertising on attribute importance. Journal of Consumer Research, 13(2), 174–195. doi:10.1086/jcr.1986.13.issue-2
  • Menon, A. M., Deshpande, A. D., Perri, M., III, & Zinkhan, G. M. (2003). Consumers’ attention to the brief summary in print direct-to-consumer advertisements: Perceived usefulness in patient-physician discussions. Journal of Public Policy & Marketing, 22(2), 181–191. doi:10.1509/jppm.22.2.181.17636
  • Moorman, C., Diehl, K., Brinberg, D., & Kidwell, D. (2004). Subjective knowledge, search locations, and consumer choice. Journal of Consumer Research, 31(3), 673–680. doi:10.1086/425102
  • O’Donoghue, A. C., Sullivan, H. W., Williams, P. A., Squire, C., Betts, K. R., Willoughby, J. F., & Parvanta, S. (2016). Consumers’ understanding of FDA approval requirements and composite scores in direct-to-consumer prescription drug print ads. Journal of Health Communication, 21(8), 927–934. doi:10.1080/10810730.2016.1179367
  • Paas, F., Renkl, A., & Sweller, J. (2004). Cognitive load theory: Instructional implications of the interaction between information structures and cognitive architecture. Instructional Science, 32(1–2), 1–8. doi:10.1023/B:TRUC.0000021806.17516.d0
  • Park, C. W., Mothersbaugh, D. L., & Feick, L. (1994). Consumer knowledge assessment. Journal of Consumer Research, 21(1), 71–82. doi:10.1086/jcr.1994.21.issue-1
  • Pieters, R., Warlop, L., & Wedel, M. (2002). Breaking through the clutter: Benefits of advertisement originality and familiarity for brand attention and memory. Management Science, 48(6), 765–781. doi:10.1287/mnsc.48.6.765.192
  • Pieters, R., & Wedel, M. (2004). Attention capture and transfer in advertising: Brand, pictorial, and text-size effects. Journal of Marketing, 68(2), 36–50. doi:10.1509/jmkg.68.2.36.27794
  • Preacher, K. J., & Hayes, A. F. (2004). SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behavior Research Methods, Instruments, & Computers, 36(4), 717–731. doi:10.3758/BF03206553
  • Punj, G. N., & Staelin, R. (1983). A model of consumer information search behavior for new automobiles. Journal of Consumer Research, 9(4), 366–380. doi:10.1086/jcr.1983.9.issue-4
  • Rosbergen, E., Pieters, R., & Wedel, M. (1997). Visual attention to advertising: A segment-level analysis. Journal of Consumer Research, 24(3), 305–314. doi:10.1086/jcr.1997.24.issue-3
  • Royne, M. B., & Myers, S. D. (2008). Recognizing consumer issues in DTC pharmaceutical advertising. Journal of Consumer Affairs, 42(1), 60–80. doi:10.1111/joca.2008.42.issue-1
  • Schiessl, M., Duda, S., Thölke, A., & Fischer, R. (2003). Eye tracking and its application in usability and media research. MMI-Interaktiv Eye Tracking, 1(6), 41–50.
  • Schwartz, L. M., & Woloshin, S. (2011). Communicating uncertainties about prescription drugs to the public: A national randomized trial. Archives of Internal Medicine, 171(16), 1463–1468. doi:10.1001/archinternmed.2011.396
  • Sheehan, K. B. (2003). Balancing acts: An analysis of Food and Drug Administration letters about direct-to-consumer advertising violations. Journal of Public Policy & Marketing, 22(2), 159–169. doi:10.1509/jppm.22.2.159.17645
  • Sheehan, K. B. (2007). Direct-to-consumer (DTC) branded drug web sites risk presentation and implications for public policy. Journal of Advertising, 36(3), 123–135. doi:10.2753/JOA0091-3367360310
  • Sheehan, K. B. (2008). Consumer friendly or reader hostile? An evaluation of the readability of DTC print ads. Health Marketing Quarterly, 23(4), 1–16.
  • Thorson, E., Chi, A., & Leavitt, C. (1992). Attention, memory, attitude, and conation: A test of the advertising hierarchy. Advances in Consumer Research, 19, 366–379.
  • Torres, I. M., Sierra, J. J., & Heiser, R. S. (2007). The effects of warning-label placement in print ads: A social contract perspective. Journal of Advertising, 36(2), 49–62. doi:10.2753/JOA0091-3367360203
  • Wei, M. L., & Delbaere, M. (2015). Do consumers perceive their doctors as influenced by pharmaceutical marketing communications? A persuasion knowledge perspective. International Journal of Pharmaceutical and Healthcare Marketing, 9(4), 330–348. doi:10.1108/IJPHM-06-2014-0033
  • Yantis, S. (2000). Goal directed and stimulus driven determinants of attentional control. In S. Monsell & J. Driver (Eds.), Control of cognitive processes: Attention and performance XVIII (pp. 73–103). Cambridge, MA: MIT Press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.